Growing genetic diagnostic initiatives, orphan drug development, and innovation in precision lipid-lowering and biologic treatments are driving sustained growth in the homozygous familial hypercholesterolemia market globally. https://www.datamintelligence.com/research-report/homozygous-familial-hypercholesterolemia-market